Treace Medical Net Worth
Treace Medical Net Worth Breakdown | TMCI |
Treace Medical Net Worth Analysis
Treace Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Treace Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Treace Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Treace Medical's net worth analysis. One common approach is to calculate Treace Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Treace Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Treace Medical's net worth. This approach calculates the present value of Treace Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Treace Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Treace Medical's net worth. This involves comparing Treace Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Treace Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Treace Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Treace Medical's net worth research are outlined below:
| Treace Medical appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 187.12 M. Net Loss for the year was (49.53 M) with profit before overhead, payroll, taxes, and interest of 163.53 M. | |
| Treace Medical Concepts currently holds about 101.53 M in cash with (34.58 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
| Treace Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 61.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Treace Medical Concepts Shares Gap Up - Still a Buy - MarketBeat |
Treace Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Treace Medical Concepts. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Treace Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Treace Medical Target Price Consensus
Treace target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Treace Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Buy |
Most Treace analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Treace stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Treace Medical Concepts, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationTreace Medical Target Price Projection
Treace Medical's current and average target prices are 10.08 and 9.05, respectively. The current price of Treace Medical is the price at which Treace Medical Concepts is currently trading. On the other hand, Treace Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Treace Medical Market Quote on 17th of February 2025
Target Price
Analyst Consensus On Treace Medical Target Price
Know Treace Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Treace Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Treace Medical Concepts backward and forwards among themselves. Treace Medical's institutional investor refers to the entity that pools money to purchase Treace Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-09-30 | 997.5 K | Soleus Capital Management, L.p. | 2024-09-30 | 887.9 K | Goldman Sachs Group Inc | 2024-09-30 | 665.2 K | Millennium Management Llc | 2024-09-30 | 554.5 K | Kornitzer Capital Management Inc | 2024-12-31 | 526.9 K | Gagnon Advisors, Llc | 2024-12-31 | 489.9 K | Northern Trust Corp | 2024-09-30 | 458.2 K | Marshall Wace Asset Management Ltd | 2024-09-30 | 426.7 K | Nuveen Asset Management, Llc | 2024-09-30 | 424.3 K | Armistice Capital, Llc | 2024-09-30 | 6.2 M | Blackrock Inc | 2024-09-30 | 4.2 M |
Follow Treace Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 627.95 M.Market Cap |
|
Project Treace Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.25) | (0.26) | |
| Return On Capital Employed | (0.29) | (0.30) | |
| Return On Assets | (0.23) | (0.24) | |
| Return On Equity | (0.32) | (0.34) |
When accessing Treace Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Treace Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Treace Medical's profitability and make more informed investment decisions.
Evaluate Treace Medical's management efficiency
Treace Medical Concepts has return on total asset (ROA) of (0.1713) % which means that it has lost $0.1713 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5069) %, meaning that it created substantial loss on money invested by shareholders. Treace Medical's management efficiency ratios could be used to measure how well Treace Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.26. The current Return On Capital Employed is estimated to decrease to -0.3. As of now, Treace Medical's Other Current Assets are increasing as compared to previous years. The Treace Medical's current Debt To Assets is estimated to increase to 0.51, while Net Tangible Assets are projected to decrease to under 39 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.04 | 2.14 | |
| Tangible Book Value Per Share | 1.72 | 1.80 | |
| Enterprise Value Over EBITDA | (19.22) | (18.26) | |
| Price Book Value Ratio | 6.47 | 6.15 | |
| Enterprise Value Multiple | (19.22) | (18.26) | |
| Price Fair Value | 6.47 | 6.15 | |
| Enterprise Value | 958.2 M | 1.3 B |
Treace Medical showcases strong leadership that adapts to market changes and drives innovation. Our analysis explores how this adaptability affects the stock's investment appeal.
Enterprise Value Revenue 3.033 | Revenue | Quarterly Revenue Growth 0.106 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Treace Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Treace Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Treace Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Treace Medical Corporate Filings
| 14th of February 2025 Other Reports | ViewVerify | |
F4 | 24th of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 13th of January 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 5th of December 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
Treace Medical Earnings Estimation Breakdown
The calculation of Treace Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Treace Medical is estimated to be -0.233175 with the future projection ranging from a low of -0.2391 to a high of -0.2286. Please be aware that this consensus of annual earnings estimates for Treace Medical Concepts is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.24 Lowest | Expected EPS | -0.23 Highest |
Treace Medical Earnings Projection Consensus
Suppose the current estimates of Treace Medical's value are higher than the current market price of the Treace Medical stock. In this case, investors may conclude that Treace Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Treace Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 7 | 80.69% | -0.25 | -0.233175 | -0.99 |
Treace Medical Earnings History
Earnings estimate consensus by Treace Medical Concepts analysts from Wall Street is used by the market to judge Treace Medical's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only Treace Medical's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.Treace Medical Quarterly Gross Profit |
|
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Treace Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Treace Medical Earnings per Share Projection vs Actual
Actual Earning per Share of Treace Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Treace Medical Concepts predict the company's earnings will be in the future. The higher the earnings per share of Treace Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Treace Medical Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Treace Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Treace Medical should always be considered in relation to other companies to make a more educated investment decision.Treace Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Treace Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-05 | 2024-09-30 | -0.27 | -0.25 | 0.02 | 7 | ||
2024-08-06 | 2024-06-30 | -0.29 | -0.29 | 0.0 | 0 | ||
2024-05-07 | 2024-03-31 | -0.3 | -0.3 | 0.0 | 0 | ||
2024-02-27 | 2023-12-31 | -0.09 | -0.1 | -0.01 | 11 | ||
2023-11-09 | 2023-09-30 | -0.26 | -0.28 | -0.02 | 7 | ||
2023-08-08 | 2023-06-30 | -0.24 | -0.2 | 0.04 | 16 | ||
2023-05-08 | 2023-03-31 | -0.23 | -0.23 | 0.0 | 0 | ||
2023-03-07 | 2022-12-31 | -0.14 | -0.08 | 0.06 | 42 | ||
2022-11-08 | 2022-09-30 | -0.29 | -0.22 | 0.07 | 24 | ||
2022-08-09 | 2022-06-30 | -0.2 | -0.31 | -0.11 | 55 | ||
2022-05-05 | 2022-03-31 | -0.2 | -0.16 | 0.04 | 20 | ||
2022-03-03 | 2021-12-31 | -0.0058 | -0.12 | -0.1142 | 1968 | ||
2021-11-04 | 2021-09-30 | -0.12 | -0.12 | 0.0 | 0 | ||
2021-08-05 | 2021-06-30 | -0.12 | -0.1 | 0.02 | 16 | ||
2021-05-25 | 2021-03-31 | -0.06 | -0.07 | -0.01 | 16 | ||
2021-03-03 | 2020-12-31 | 0 | 0.06 | 0.06 | 0 | ||
2020-03-31 | 2019-12-31 | 0 | -0.0476 | -0.0476 | 0 |
Treace Medical Corporate Management
| Shana Zink | Senior Reimbursement | Profile | |
| Julie Dewey | Chief Officer | Profile | |
| Scot JD | Chief Secretary | Profile | |
| Thomas Timbie | Independent Director | Profile | |
| John Treace | Founder CEO | Profile | |
| Sean Scanlan | Chief Officer | Profile | |
| Nathan Minnich | Senior Marketing | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.99) | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets | Return On Equity |
The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.